What Diadema Partners LP reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 2026172 · Filed Nov 16, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 600K |
| ±0% |
| $37.4M |
| 4.8% |
| 1.1M | −6.7% | $37.1M | 4.8% |
VIKING THERAPEUTICS INCNOTE 2.000%10/1 | 1M | New | $32.6M | 4.2% |
| 297K | +102.2% | $28.2M | 3.6% |
| 47.5K | New | $25.7M | 3.3% |
UTHRUnited Therapeutics Corp | 46.2K | −12.8% | $25M | 3.2% |
| 250K | +150.0% | $24.6M | 3.1% |
| 251.7K | +28.0% | $23.9M | 3.1% |
| 330.6K | ±0% | $20.6M | 2.6% |
COGTCogent Biosciences, Inc. | 641.9K | +30.0% | $20.6M | 2.6% |
| 518.1K | New | $18.5M | 2.4% |
| 160.9K | +7.5% | $18M | 2.3% |
ABVXAbivax S.A. | 178.4K | +9.0% | $17.7M | 2.3% |
BRIDGEBIO PHARMA INCNOTE 1.750% 3/0 | 250K | ±0% | $16.5M | 2.1% |
| 960.2K | +11.6% | $16.2M | 2.1% |
BMRNBioMarin Pharmaceutical Inc | 255.4K | −18.4% | $15.3M | 2% |
RVMDRevolution Medicines, Inc. | 70K | −49.7% | $14.4M | 1.8% |
| 100K | ±0% | $14.3M | 1.8% |
VKTXViking Therapeutics, Inc. | 433.2K | −2.0% | $14.1M | 1.8% |
| 100K | New | $14M | 1.8% |
| 137.7K | −45.4% | $13.6M | 1.7% |
| 801.4K | +300.7% | $13.6M | 1.7% |
| 105.4K | ±0% | $12.8M | 1.6% |
| 100K | −51.5% | $11.5M | 1.5% |
| 114.6K | −67.2% | $11.3M | 1.5% |
| 197.8K | +304.5% | $11.3M | 1.4% |
| 153.1K | +188.3% | $8.7M | 1.1% |
| 44.4K | New | $8.6M | 1.1% |
SPDR SERIES TRUSTST STR SP BIOTPut option | 50K | New | $7.9M | 1% |
| 257.2K | New | $7.8M | 1% |
BBIOBridgeBio Pharma, Inc. | 104K | New | $6.8M | 0.9% |
IMCRImmunocore Holdings plc | 221.8K | −13.0% | $6.7M | 0.9% |
FDMT4D Molecular Therapeutics, Inc. | 421.1K | −26.3% | $6M | 0.8% |
| 235.4K | ±0% | $5.7M | 0.7% |
| 800K | +26.2% | $5.5M | 0.7% |
VRDNViridian Therapeutics, Inc.DE | 257.1K | +157.1% | $5.3M | 0.7% |
| 199.3K | −33.3% | $4.8M | 0.6% |
| 497.3K | +51.0% | $4.7M | 0.6% |
| 484.4K | −9.4% | $4.6M | 0.6% |
| 150K | New | $4.5M | 0.6% |
JNJJohnson & Johnson | 17K | −22.7% | $4.5M | 0.6% |
| 317K | ±0% | $4.2M | 0.5% |
INDVSupernus, Inc. | 117.5K | +74.1% | $4.2M | 0.5% |
PCVXVaxcyte, Inc. | 72.9K | +61.6% | $4.1M | 0.5% |
REPLReplimune Group, Inc. | 305K | New | $4M | 0.5% |
RCUSArcus Biosciences, Inc. | 153.8K | −31.3% | $4M | 0.5% |
| 200K | New | $3.8M | 0.5% |
KODKodiak Sciences Inc. | 39K | −82.1% | $3.7M | 0.5% |
LQDALiquidia Corp | 120K | New | $3.6M | 0.5% |
MBXMBX Biosciences, Inc. | 60K | New | $3.5M | 0.5% |
| 304.2K | New | $3.3M | 0.4% |
| 124.1K | +0.1% | $3.2M | 0.4% |
| 100K | New | $3.2M | 0.4% |
| 100K | New | $3.2M | 0.4% |
| 250K | +150.0% | $3.1M | 0.4% |
| 100K | New | $3M | 0.4% |
| 200K | New | $3M | 0.4% |
RYTMRhythm Pharmaceuticals, Inc. | 30K | New | $2.9M | 0.4% |
PHVSPharvaris N.V. | 90K | +206.9% | $2.9M | 0.4% |
AVTXAvalo Therapeutics, Inc. | 181.9K | New | $2.8M | 0.4% |
| 200K | −50.0% | $2.5M | 0.3% |
| 200K | ±0% | $2.4M | 0.3% |
CRVSCorvus Pharmaceuticals, Inc. | 204.8K | −30.5% | $2.4M | 0.3% |
MNKDMannkind Corp | 604K | +3,674.4% | $2.4M | 0.3% |
INSMInsmed Inc | 18.5K | New | $2.1M | 0.3% |
BCRXBiocryst Pharmaceuticals Inc | 250K | New | $2.1M | 0.3% |
IVAInventiva S.A. | 553.1K | −25.3% | $2.1M | 0.3% |
TSHATaysha Gene Therapies, Inc. | 422.6K | −19.1% | $2.1M | 0.3% |
| 200K | ±0% | $2M | 0.3% |
SPRBSpruce Biosciences, Inc. | 40.4K | +34.8% | $2M | 0.3% |
EWTXEdgewise Therapeutics, Inc. | 44.3K | −83.7% | $1.8M | 0.2% |
PRTAProthena Corp Public Ltd Co | 208.2K | +39.3% | $1.7M | 0.2% |
PTHSPelthos Therapeutics Inc. | 80.8K | +226.0% | $1.7M | 0.2% |
| 200K | New | $1.6M | 0.2% |
| 20K | ±0% | $1.6M | 0.2% |
AMLXAmylyx Pharmaceuticals, Inc. | 53.2K | New | $1.5M | 0.2% |
| 133.4K | ±0% | $1.5M | 0.2% |
| 200K | ±0% | $1.5M | 0.2% |
BCYCBicycle Therapeutics PLC | 398.9K | −13.8% | $1.5M | 0.2% |
| 100K | New | $1.5M | 0.2% |
PRQRProQR Therapeutics N.V. | 826.3K | −10.8% | $1.4M | 0.2% |
RLMDRelmada Therapeutics, Inc. | 361.4K | ±0% | $1.4M | 0.2% |
| 50K | New | $1.3M | 0.2% |
PHATPhathom Pharmaceuticals, Inc. | 180K | +38.5% | $1.3M | 0.2% |
JBIOJade Biosciences, Inc. | 91.3K | New | $1.3M | 0.2% |
MLYSMineralys Therapeutics, Inc. | 50K | −11.3% | $1.3M | 0.2% |
VERAVera Therapeutics, Inc. | 38K | −34.0% | $1.2M | 0.2% |
MLTXMoonLake Immunotherapeutics | 100K | New | $1.2M | 0.1% |
ORKAOruka Therapeutics, Inc. | 13.2K | −52.6% | $1.1M | 0.1% |
| 400K | ±0% | $1M | 0.1% |
MGNXMacrogenics Inc | 262.1K | −30.0% | $1M | 0.1% |
| 70K | New | $939.4K | 0.1% |
| 192.6K | −75.7% | $904.3K | 0.1% |
JSPRJasper Therapeutics, Inc. | 35.3K | New | $873.5K | 0.1% |
CTNMContineum Therapeutics, Inc. | 64.5K | −46.1% | $866.2K | 0.1% |
ADILAzora Therapeutics, Inc. (DE) | 181.9K | New | $729.4K | 0.1% |
ENTXEntera Bio Ltd. | 245.1K | +953.7% | $713.2K | 0.1% |
SMMTSummit Therapeutics Inc. | 41.9K | −30.2% | $708.3K | 0.1% |
NBPNovaBridge Biosciences | 500K | New | $682.5K | 0.1% |
QNRXQuoin Pharmaceuticals Ltd. | 146.4K | New | $667.8K | 0.1% |
| 30K | New | $656.1K | 0.1% |
KARDKardigan, Inc. | 44K | New | $648.6K | 0.1% |
TRDAEntrada Therapeutics, Inc. | 100K | New | $635K | 0.1% |
TNGXTango Therapeutics, Inc. | 25K | New | $623.8K | 0.1% |
SLSSELLAS Life Sciences Group, Inc. | 50K | New | $615.5K | 0.1% |
LRMRLarimar Therapeutics, Inc. | 185.7K | +26.6% | $593.3K | 0.1% |
SLNSilence Therapeutics plc | 135K | New | $540K | 0.1% |
NRIXNurix Therapeutics, Inc. | 21.5K | −82.3% | $510.7K | 0.1% |
FULCFulcrum Therapeutics, Inc. | 133.4K | New | $493.5K | 0.1% |
ELVNEnliven Therapeutics, Inc. | 10K | ±0% | $458.4K | 0.1% |
TLPHTalphera, Inc. | 378K | +146.2% | $438.5K | 0.1% |
| 150K | ±0% | $402K | 0.1% |
| 102.5K | New | $399.8K | 0.1% |
XENEXenon Pharmaceuticals Inc. | 10K | New | $371.9K | 0.1% |
| 275.2K | ±0% | $335.7K | 0.1% |
AEMDAethlon Medical Inc | 50K | New | $326K | 0.1% |
ABEOAbeona Therapeutics Inc. | 51.1K | New | $268.4K | 0.1% |
ARDXArdelyx, Inc. | 77.1K | −74.5% | $263.8K | 0.1% |
| 50K | −85.8% | $211.5K | 0.1% |
OCGNOcugen, Inc. | 200K | ±0% | $206K | 0.1% |
| 88.2K | −77.3% | $205.5K | 0.1% |
| 108.2K | New | $187.2K | 0.1% |
| 100K | ±0% | $182K | 0.1% |
ATTOAttovia Therapeutics, Inc. | 9.7K | New | $166.3K | 0.1% |
IMTXImmatics N.V. | 17.6K | New | $154.4K | 0.1% |
HRTXHeron Therapeutics, Inc. | 458.7K | ±0% | $143.8K | 0.1% |
AYTUAytu Biopharma, Inc | 67.2K | −54.8% | $143.8K | 0.1% |
JATTJATT II Acquisition Corp. | 12.2K | +35.0% | $136.9K | 0.1% |
CLRBCellectar Biosciences, Inc. | 71.4K | −48.4% | $131.3K | 0.1% |
| 88.5K | New | $108.9K | 0.1% |
PALIPalisade Bio, Inc. | 69.5K | New | $93.9K | 0.1% |
QUREuniQure N.V. | 3.4K | New | $82.1K | 0.1% |
ENTAEnanta Pharmaceuticals Inc | 5.5K | New | $72.5K | 0.1% |
LLYEli Lilly & Co | 60 | New | $69.4K | 0.1% |
TVRDTvardi Therapeutics, Inc. | 48.5K | +192.0% | $60.6K | 0.1% |
| 50K | New | $52K | 0.1% |
APREAprea Therapeutics, Inc. | 28.9K | −35.7% | $21.7K | 0.1% |
OTLKOutlook Therapeutics, Inc. | 35K | New | $20.1K | 0.1% |
ELTXElicio Therapeutics, Inc. | 9.4K | New | $17.2K | 0.1% |
| 6.5K | −94.2% | $11.8K | 0.1% |
RPRXRoyalty Pharma plc | 194 | New | $11.3K | 0.1% |
MXCTMaxcyte, Inc. | 8.2K | New | $9.2K | 0.1% |
| 500 | ±0% | $5.5K | 0.1% |
| 12.5K | ±0% | $3.8K | 0.1% |
| 1K | ±0% | $2.9K | 0.1% |
| 200 | −100.0% | $2.6K | 0.1% |
NTLAIntellia Therapeutics, Inc. | 124 | New | $1.5K | 0.1% |